Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs Elicio Therapeutics, Inc. (ELTX)

Caribou Biosciences, Inc. and Elicio Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Elicio Therapeutics, Inc. are of similar size ($49.8M and $48.2M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against 10.0%. Elicio Therapeutics, Inc. has the higher net margin (0.00% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Elicio Therapeutics, Inc. leads on 9 and Caribou Biosciences, Inc. on 7.

Valuation

Metric CRBU ELTX Biotechnology median
P/E n/m n/m 8.50
P/S 4.73 1.04 9.71
P/B 0.48 3.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.60 n/m 0.64
EV/Sales (6.46) 0.59 9.21
Earnings yield (229.79%) (139.10%) (33.15%)
Free cash flow yield (279.78%) (125.90%) (25.50%)

Profitability

Metric CRBU ELTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,090.90%) 0.00% 0.00%
Net margin (1,030.42%) 0.00% 0.00%
Free cash flow margin (1,323.30%) 0.00% 0.00%
Return on equity (78.27%) (774.56%) (56.36%)
Return on assets (56.87%) (124.36%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU ELTX Biotechnology median
Revenue growth (TTM) 10.02% 921.02% 6.02%
EPS growth (last fiscal year) 3.64% 39.29% 30.26%
Revenue growth, 5-year CAGR (2.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU ELTX Biotechnology median
Debt to equity 0.00 1.20 0.00
Current ratio 6.49 2.77 4.72
Net debt to EBITDA 0.96 0.25 0.96

Dividend

Metric CRBU ELTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBU ELTX Biotechnology median
Market cap 49.82m 48.22m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack